Video

What is the Future of Biosimilars?

Author(s):

Davy James, Managing Editor

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.

Related Videos
Small cell lung cancer -- Image credit: LASZLO | stock.adobe.com
Image credit: TensorSpark | stock.adobe.com
Related Content
CDC office in Atlanta, Georgia | Image Credit: © Tada Images - stock.adobe.com
March 21st 2025

CDC Launches Study on Vaccine-Autism Link Amid Ongoing Measles Outbreak

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Blood test for C3, C4 protein detection | Image Credit: © MdBabul - stock.adobe.com
March 21st 2025

Iptacopan Receives Third FDA Approval for Adult Patients With C3 Glomerulopathy

Alexandra Gerlach, Associate Editor
The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma
January 31st 2025

The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma

Alexandra Gerlach, Associate Editor
Close-up of actin and myelin filaments weaved together | Image Credit: © Shutter2U - stock.adobe.com
March 20th 2025

Researchers Identify BeeR, a Novel Protein That May Enhance Drug Delivery in Cancer Care

Alexandra Gerlach, Associate Editor
Vial of pembrolizumab | Image Credit: © Soni's - stock.adobe.com
March 19th 2025

Pembrolizumab in Combination With Platinum-, Fluoropyrimidine-Based Chemotherapy Receives FDA Approval for GEJ

Alexandra Gerlach, Associate Editor